Development of poly-(d,l-lactide–coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis
- 30 May 2001
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 72 (1-3) , 13-24
- https://doi.org/10.1016/s0168-3659(01)00258-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Comparison of the rates of deamidation, diketopiperazine formation, and oxidation in recombinant human vascular endothelial growth factor and model peptidesAAPS PharmSci, 2000
- Hydrolytic degradation of devices based on poly(dl-lactic acid) size-dependencePublished by Elsevier ,1999
- Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass SurgeryCirculation, 1999
- The delivery of angiogenic factors to the heart by microsphere therapyNature Biotechnology, 1998
- Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation developmentAdvanced Drug Delivery Reviews, 1997
- A month–long effect from a single injection of microencapsulated human growth hormoneNature Medicine, 1996
- The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic PotencyJournal of Biological Chemistry, 1996
- Definition of Two Angiogenic Pathways by Distinct α v IntegrinsScience, 1995
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- Biocompatible controlled release polymers for delivery of polypeptides and growth factorsJournal of Cellular Biochemistry, 1991